Literature DB >> 499289

Biguanide-induced lactic acidosis in Finland.

T Korhonen, J Idänpään-Heikkilä, A Aro.   

Abstract

Twenty-four patients with biguanide-induced lactic acidosis were reported to the Adverse Drug Reaction Register of the Finnish National Board of Health from 1974-1977. Of them, 23 had been treated with phenformin and one with metformin. The mean age of the patients was 71 years, and all but one were more than 65 years of age. The mortality rate was 63%. One patient had cirrhosis of the liver and one was already known tohave had impaired renal function. Fourteen of the patients had a normal serum creatinine concentration either before or after the development of lactic acidosis. Thus, in most patients it had not been possible to prevent development of lactic acidosis by observing the contraindications to biguanide therapy. Most patients had some form of co-existing cardiovascular disease. Tetracycline therapy was a probable precipitating factor in three cases. Based on the statistics of biguanide consumption in Finland, the annual incidence of biguanide-induced lactic acidosis in 1976 and 1977 was between 1/2000 and 1/3000 and that of fatal lactic acidosis was 1/4000.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 499289     DOI: 10.1007/bf00561739

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Renal disease and the metabolic effects of tetracycline.

Authors:  M E SHILS
Journal:  Ann Intern Med       Date:  1963-03       Impact factor: 25.391

2.  Phenethyldiguanide: a dangerous side-effect.

Authors:  R S WALKER; A L LINTON
Journal:  Br Med J       Date:  1959-11-14

3.  Effect of large doses of aureomycin on human liver.

Authors:  M H LEPPER; C K WOLFE; H J ZIMMERMAN; E R CALDWELL; H W SPIES; H F DOWLING
Journal:  AMA Arch Intern Med       Date:  1951-09

4.  Phenformin, tetracycline, and lactic acidosis.

Authors:  C K Tashima
Journal:  Br Med J       Date:  1971-11-27

5.  Lactic acidosis.

Authors:  K G Alberti; M Nattrass
Journal:  Lancet       Date:  1977-07-02       Impact factor: 79.321

6.  Epidemiology of adverse drug reactions to phenformin and metformin.

Authors:  U Bergman; G Boman; B E Wiholm
Journal:  Br Med J       Date:  1978-08-12

7.  Phenformin-induced lacticacidosis precipitated by tetracycline.

Authors:  A Aro; T Korhonen; M Halinen
Journal:  Lancet       Date:  1978-03-25       Impact factor: 79.321

8.  [Lactic acidosis associated with various types of biguanide-therapy (phenformin, buformin, metformin). Results of a survey of the years 1972--1977 in Switzerland (author's transl)].

Authors:  W Berger; R Amrein
Journal:  Schweiz Rundsch Med Prax       Date:  1978-05-02

9.  The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden.

Authors:  U Bergman; P Elmes; M Halse; T Halvorsen; H Hood; P K Lunde; F Sjöqvist; O L Wade; B Westerholm
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

10.  Can phenformin-induced lactic acidosis be prevented?

Authors:  E A Gale; R B Tattersall
Journal:  Br Med J       Date:  1976-10-23
View more
  2 in total

1.  The status of metformin in Canada.

Authors:  O J Lucis
Journal:  Can Med Assoc J       Date:  1983-01-01       Impact factor: 8.262

2.  Do Patients Die with or from Metformin-Associated Lactic Acidosis (MALA)? Systematic Review and Meta-analysis of pH and Lactate as Predictors of Mortality in MALA.

Authors:  Adam Blumenberg; Roshanak Benabbas; Richard Sinert; Amy Jeng; Sage W Wiener
Journal:  J Med Toxicol       Date:  2020-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.